We discuss the regulators violating their own rules, then re-writing their rules to match the violations for their “preferred” mRNA companies, while also simultaneously holding back any other aspiring mRNA pharma developers. My personal opinion, mRNA category has a very long way to go as a medicine, and absolutely should not be allowed for any prophylactic treatment or a treatment that is applied to broad populations due to insurmountable safety and manufacturing issues.
Government investment in mega biopharma manufacturing plants all over the world is another concerning trend - what are they investing in, given that there is hardly any demand anymore for these poisonous injections?
TNT Radio - Discussion with Jesse Zurawell, February 14, 2023